CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 165 filers reported holding CHEMOCENTRYX INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $98,188,000 | +6.4% | 1,706,426 | -25.7% | 5.88% | -14.4% |
| Q1 2020 | $92,325,000 | +22.8% | 2,297,779 | +20.8% | 6.88% | +49.8% |
| Q4 2019 | $75,211,000 | +565.6% | 1,901,667 | +14.1% | 4.59% | +310.6% |
| Q3 2019 | $11,300,000 | -27.1% | 1,666,667 | 0.0% | 1.12% | +1.9% |
| Q2 2019 | $15,500,000 | -33.0% | 1,666,667 | 0.0% | 1.10% | -24.9% |
| Q1 2019 | $23,150,000 | – | 1,666,667 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |